CBD Shows Potential for Schizophrenia Treatment

Research on schizophrenia-affected rat models shows potential for #CBD to minimize many #schizophrenia symptoms

Cannabidiol (CBD) may have potential as a schizophrenia therapeutic agent. Individuals with schizophrenia exhibit decreased activity in choline acetyltransferase (ChAT) activity, an enzyme associated with cognitive functioning. In rat models mimicking schizophrenia, affected rats treated with CBD exhibited normal ChAt activity, while their untreated counterparts exhibited reduced activity.   

CED Foundation Google Drive:

Read Here or Download:

Benjamin Caplan, MDCBD Shows Potential for Schizophrenia Treatment